Success Stories: EB-1B Petition Approved for Senior Statistician in New Jersey in the Field of Statistics
inClient’s Testimonial:
Thank you for your fantastic work! [...] Thank you for your professional and top quality service. I will post good comment on your work on mitbbs.com.
We Received EB-1B Approval for a Senior Statistician in the Field of Statistics on December 15th, 2014 (Approval Notice)
Position at the Time of Case Filing: Senior Statistician
Petitioner: Private Company
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: December 15th, 2014
Processing Time: 7 Months, 14 Days
At North America Immigration Law Group- WeGreened.com, we recently received an EB-1B approval for a Senior Statistician in the field of Statistics. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB-1B petition. His specialized research has focused on the improvement of clinical trial design and the development of information important to economic policy. His research work had resulted in 6 peer-reviewed scientific articles and numerous presentations at national and international conferences. He had also reviewed 15 manuscripts for journals at the time we filed the case. Furthermore, the beneficiary had a total of 69 citations to his work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. The petitioner in this case was a private company. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “[Client]developed a hybrid clinical trial design that allows for the possibility of assessing non-inferiority with a much smaller sample size than is usually required. Ultimately, the hybrid design … offers an alternative method for establishing non-inferiority when marginal superiority is expected. His method significantly reduces the required sample size, which is very relevant for medical safety since minimizing the exposure of a trial medication to children with cystic fibrosis is always desirable for safety reasons.” It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements. With the proof and documentation that we provided, his case was approved in 7 months and 14 days.

